Identification of aspirin analogues that repress NF-κB signalling and demonstrate anti-proliferative activity towards colorectal cancer in vitro and in vivo

Ann-Katrin Claudius, Chandra S. Kankipati, Rajagopal S. Kilari, Sadiya Hassan, Kerry Guest, Steven T. Russell, Chris J. Perry, Lesley A. Stark, Iain D. Nicholl*

*Corresponding author for this work

Research output: Contribution to journalArticle

Abstract

Substantial evidence indicates that aspirin and related non-steroidal anti-inflammatory drugs (NSAIDs) have potential as chemopreventative/therapeutic agents. However, these agents cannot be universally recommended for prevention purposes due to their potential side-effect profiles. Here, we compared the growth inhibitory and mechanistic activity of aspirin to two novel analogues, diaspirin (DiA) and fumaryl diaspirin (F-DiA). We found that the aspirin analogues inhibited cell proliferation and induced apoptosis of colorectal cancer cells at significantly lower doses than aspirin. Similar to aspirin, we found that an early response to the analogues was a reduction in levels of cyclin D1 and stimulation of the NF-κB pathway. This stimulation was associated with a significant reduction in basal levels of NF-κB transcriptional activity, in keeping with previous data for aspirin. However, in contrast to aspirin, DiA and F-DiA activity was not associated with nucleolar accumulation of RelA. For all assays, F-DiA had a more rapid and significant effect than DiA, identifying this agent as particularly active against colorectal cancer. Using a syngeneic colorectal tumour model in mice, we found that, while both agents significantly inhibited tumour growth in vivo, this effect was particularly pronounced for F-DiA. These data identify two compounds that are active against colorectal cancer in vitro and in vivo. They also identify a potential mechanism of action of these agents and shed light on the chemical structures that may be important for the antitumour effects of aspirin.

Original languageEnglish
Pages (from-to)1670-1680
Number of pages11
JournalOncology Reports
Volume32
Issue number4
Early online date31 Jul 2014
DOIs
Publication statusPublished - Oct 2014

Bibliographical note

Oncology Reports is the original source

Keywords

  • anti-proliferative activity
  • cyclin D1
  • diaspirin
  • fumaryl diaspirin
  • implantable colorectal cancer model
  • NF-κB
  • tumour cell lines

Fingerprint Dive into the research topics of 'Identification of aspirin analogues that repress NF-κB signalling and demonstrate anti-proliferative activity towards colorectal cancer in vitro and in vivo'. Together they form a unique fingerprint.

Cite this